# 2026-04289: Pharma Firm Seeks Approval to Import Powerful Pain Drug

2026-04289, Importer of Controlled Substances Application: Amneal Pharmaceuticals, LLC, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-03-04, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 3, 2026. Such persons may also file a written request for a hearing on the application on or before April 3, 2026. (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-04289
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-04289
- Title: Importer of Controlled Substances Application: Amneal Pharmaceuticals, LLC
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 10626
- Published: 2026-03-04
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 3, 2026. Such persons may also file a written request for a hearing on the application on or before April 3, 2026.
- Comments close: 2026-04-03
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Pharma Firm Seeks Approval to Import Powerful Pain Drug

## Summary

Amneal Pharmaceuticals wants to become an official importer of a powerful drug called Remifentanil, which is tightly controlled by the government. People who make or import similar drugs can share their thoughts or ask for a hearing by April 3, 2026. This move could affect how this drug is brought into the U.S., but no costs or fees are mentioned yet.

## Abstract

Amneal Pharmaceuticals, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-04289 on federalregister.gov](https://www.federalregister.gov/documents/2026/03/04/2026-04289/importer-of-controlled-substances-application-amneal-pharmaceuticals-llc)
- [2026-04289 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-03-04/pdf/2026-04289.pdf)

## Related
- [Previous: 2026-04286, Media Bureau Seeks Comment on Sports Broadcasting Practices and Marketplace Dev…](https://policyrisk.com/federal-register/2026-04286)
- [Next: 2026-04290, Proposed Collection; Comment Request](https://policyrisk.com/federal-register/2026-04290)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-04289 (as of 2026-06-08).
